Baqsimi Unjoni Ewropea - Rumen - EMA (European Medicines Agency)

baqsimi

eli lilly nederland b.v. - glucagon - diabetul zaharat - pancreatic hormoni, hormoni glycogenolytic - baqsimi este indicat pentru tratamentul hipoglicemiei severe la adulți, adolescenți și copii cu vârsta de 4 ani și peste, cu diabet zaharat.

Retsevmo Unjoni Ewropea - Rumen - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agenți antineoplazici - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Mounjaro Unjoni Ewropea - Rumen - EMA (European Medicines Agency)

mounjaro

eli lilly nederland b.v. - tirzepatide - diabetul zaharat, tip 2 - medicamente utilizate în diabet - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 și 5.

Rayvow Unjoni Ewropea - Rumen - EMA (European Medicines Agency)

rayvow

eli lilly nederland b.v. - lasmiditan succinate - tulburări ale migrenei - analgezice - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

Omvoh Unjoni Ewropea - Rumen - EMA (European Medicines Agency)

omvoh

eli lilly nederland b.v. - mirikizumab - colită, ulcerativă - imunosupresoare - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

Jaypirca Unjoni Ewropea - Rumen - EMA (European Medicines Agency)

jaypirca

eli lilly nederland b.v. - pirtobrutinib - limfom, mantle-cell - protein kinazei - treatment of mantle cell lymphoma (mcl).